Your account is not claimed yet. You can sign up with ORCID to claim your account.

Catherine D Van Raamsdonk

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Venues

Pigment cell & melanoma research

eLife

Nature communications

University of British Columbia

Princeton University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of British Columbia

Canada

Associate Professor :: Medical Genetics

Education History

Princeton University

United States

PHD :: Molecular Biology

Publications

Sandra Schrenk, Lindsay J Bischoff, Jillian Goines, Yuqi Cai, Shruti Vemaraju, Yoshinobu Odaka, Samantha R Good, Joseph S Palumbo, Sara Szabo, Damien Reynaud, Catherine D Van Raamsdonk, Richard A Lang, Elisa Boscolo
MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ. Nature communications 14 (1) (2023)
Oscar Urtatiz, Amanda Haage, Guy Tanentzapf, Catherine D Van Raamsdonk
Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma. eLife 10 (2021)
Fagun Jain, Anne Longakit, Jenny Li-Ying Huang, Catherine D Van Raamsdonk
Endothelin signaling promotes melanoma tumorigenesis driven by constitutively active GNAQ. Pigment cell & melanoma research 33 (6) (2020)
Oscar Urtatiz, Courtney B Cook, Jenny L-Y Huang, Iwei Yeh, Catherine D Van Raamsdonk
GNAQQ209L expression initiated in multipotent neural crest cells drives aggressive melanoma of the central nervous system. Pigment cell & melanoma research 33 (1) (2019)
Grace Tharmarajah, Ulrich Eckhard, Fagun Jain, Giada Marino, Anna Prudova, Oscar Urtatiz, Helmut Fuchs, Martin H de Angelis, Christopher M Overall, Catherine D Van Raamsdonk
Melanocyte development in the mouse tail epidermis requires the Adamts9 metalloproteinase. Pigment cell & melanoma research 31 (6) (2018)
Oscar Urtatiz, Atefeh M V Samani, Janel L Kopp, Catherine D Van Raamsdonk
Rapid melanoma induction in mice expressing oncogenic BrafV600E using Mitf-cre. Pigment cell & melanoma research 31 (4) (2018)

Catherine D Van Raamsdonk.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Catherine D Van Raamsdonk